All blog posts
Total 3 results for
Showing 3 out of 3 results
23 11월 2022
SANCTION IMPOSED BY THE SPANISH COMPETITION AUTHORITY ON A PHARMA COMPANY FOR MISUSING LITIGATION STRATEGIES REGARDING PATENTS
11 10월 2022
Update on the Teva Copaxone EU case. The EU Commission issues a Statement of Objections against Teva over alleged anti-competitive conduct consisting of misuse of divisional patents and a disparagement campaign against its closest competitor
09 2월 2022
Competition law in the pharma sector – Developments and what’s to come in 2022
Showing 3 out of 3 results